webleads-tracker

Pharma Compliance Info The Data Protection Regulation: Balancing Patient Confidentiality and Legitimate Research Demands Data Protection

The Data Protection Regulation: Balancing Patient Confidentiality and Legitimate Research Demands

Discussions on the Data Protection Regulation within Science Europe and in particular in the Medical Sciences Committee of Science Europe started back in 2012. It was the topic of one of the first Position Statements “on the proposed European General Data Protection Regulation”, delivered in May 2013, and signed by 50 Member Organisations from 28 countries.
Among the seven recommendations, one for example called for maintaining the provision of Article 83 – processing for historical, statistical and scientific research purposes – and the support of its associated provisions and derogations as laid out by the Commission’s proposal. The processing of personal data for scientific research purposes in Europe is carried out while maintaining high standards of protection for individuals. Scientific research that relies on personal data is conducted within a robust ethical framework and follows internationally-recognised guidelines. Therefore, protecting individual privacy and the undertaking of bona fide scientific research of public benefit are compatible objectives.
Since then, more than two years have passed, with intense – and often controversial – discussions and negotiations within the European Institutions, which will hopefully reach an agreement under the Luxembourg Presidency at the next Justice Council meeting on 3/4 December.
To read the article by Bonnie Wolff-Boenisch

Check Also

Pharma Compliance Info CNIL | Blockchain et RGPD : quelles solutions pour un usage responsable en présence de données personnelles ? Data Protection

CNIL | Blockchain et RGPD : quelles solutions pour un usage responsable en présence de données personnelles ?

La Blockchain est une technologie au potentiel de développement fort qui suscite de nombreuses questions, …

X